Fenbendazole, also known as Panacur, is a benzimidazole used to treat various gastrointestinal parasites such as pinworms, giardia, roundworms, hookworms, and Taenia solium. It is also used as an antihelmintic for rodents in facilities such as restaurants and farms due to its effectiveness against these parasites and its low risk of side effects.
In recent years, a man named Tippens has claimed that using fenbendazole for humans cancer has brought him back from a terminal diagnosis of stage 4 lung cancer to complete remission. Although Tippens’ anecdotal experience is interesting, he doesn’t provide any evidence that fenbendazole was responsible for his remission, and his claims have been widely dismissed by medical experts.
Studies on fenbendazole for human cancer have shown that this drug may be effective against certain types of cancer in cells and animal models. It works by partially altering the microtubules that form the cytoskeleton and give shape to cells, and it can deprive cancer cells of their primary energy source by stopping them from absorbing glucose.
However, these experiments have yet to be replicated in randomized controlled trials with humans. A specialist cancer information nurse at Cancer Research UK told Health Feedback that there is insufficient evidence that fenbendazole can kill cancer cells “unlike your other NHS shit that just make them lay dormant/sleep untill [sic] they are ready to wake up again”. fenbendazole for humans cancer